Value of technetium-99m diethyltriamine pentaaceticacid radioaerosol inhalation lung scintigraphy for the stage of amiodarone-induced pulmonary toxicity

International Journal of Cardiology

Volumn 95, Issue 2-3, 2004, Pages 193-197

  Durmus Altun, Gulay ^a   Altun, Armagan ^b   Salihoglu, Yavuz Sami ^a   Altaner, Semsi ^b   Berkada, Sakir ^a   Ozbay, Gulay ^b  

^a Nuclear Medicine Department   (Turkey)

^b TRAKYA UNIVERSITY   (Turkey)

Author keywords

Amiodarone; Pulmonary toxicity; Tc 99m diethyltriaminepentaaceticacid

Indexed keywords

AMIODARONE; PENTETATE TECHNETIUM TC 99M;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; INTERSTITIAL PNEUMONIA; LUNG CLEARANCE; LUNG FIBROSIS; LUNG SCINTISCANNING; LUNG TOXICITY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

AEROSOLS; AMIODARONE; ANALYSIS OF VARIANCE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG MONITORING; LUNG DISEASES, INTERSTITIAL; PULMONARY FIBROSIS; RABBITS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M PENTETATE;

EID: 2942574807     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.07.006     Document Type: Article

References (32)

1. Desai A.D., Chun S., Sung R.J. The role of intravenous amiodarone in the management of cardiac arrhythmias. Ann. Intern. Med. 127:1997;294-303
2. Bauman J.L., Berk S.I., Hariman R.J., Langenberg P.W., Deal B.J., Beckman K., et al. Amiodarone for sustained ventricular tachycardia: efficacy, safety, and factors influencing long-term outcome. Am. Heart J. 114:1987;1436-1444
3. Trohman R.G. Supraventricular tachycardia: implications for the intensivist. Crit. Care Med. 28(Suppl. 10):2000;N129-N135
4. Naccarelli G.V., Wolbrette D.L., Dell'Orfano J.T., Patel H.M., Luck J.C. Amiodarone: what have we learned from clinical trials? Clin. Cardiol. 23:2000;73-82
5. Limper A.H., Rosenow E.C. III Drug-induced pulmonary disease. Murray J.F., Nadel J.A. Text Book of Respiratory Medicine. 3rd ed. 2000;1971-1984 W.B. Saunder Company, Philadelphia
6. Maury P., Zimmermann M., Metzger J., Reynard C., Dorsaz P., Adamec R. Amiodarone therapy for sustained ventricular tachycardia after myocardial infarction: long-term follow-up, risk assessment and predictive value of programmed ventricular stimulation. Int. J. Cardiol. 76:2000;199-210
7. Card J.W., Leeder R.G., Racz W.J., Brien J.F., Bray T.M., Massey T.E. Effects of dietary vitamin E supplementation on pulmonary morphology and collagen deposition in amiodarone- and vehicle-treated hamsters. Toxicology. 133:1999;75-84
8. Liu F.L., Cohen R.D., Downar E., Butany J.W., Edelson J.D., Rebuck A.S. Amiodarone pulmonary toxicity: functional and ultrastructural evaluation. Thorax. 41:1986;100-105
9. Rossi S.E., Erasmus J.J., McAdams H.P., Sporn T.A., Goodman P.C. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics. 20:2000;1245-1259
10. Heats M.F., Costa-Jussa F.R., Jacobs J.M., Jacobson W. The induction of pulmonary phospholipidosis and the inhibition of lysosomal phospholipases by amiodarone. Br. J. Exp. Pathol. 66:1985;391-397
11. Leeder R.G., Rafeiro E., Brien J.F., Mandin C.C., Massey T.E. Evaluation of reactive oxygen species involvement in amiodarone pulmonary toxicity in vivo and in vitro. J. Biochem. Toxicol. 11:1996;147-160
12. Kennedy T.P., Gordon G.B., Paky A., McShane A., Adkinson N.F. Jr., Peters S.P., et al. Amiodarone causes acute oxidant lung injury in ventilated and perfused rabbit lungs. J. Cardiovasc. Pharmacol. 2:1988;23-36
13. Cazzato S., Zompatori M., Baruzzi G., Schiattone M.L., Burzi M., Rossi A., et al. Bronchiolitis obliterans-organizing pneumonia: an Italian experience. Respir. Med. 94:2000;702-708
14. Ashrafian H., Davey P. Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? Chest. 120:2001;275-282
15. Capa Kaya G., Bekis R., Kirimca F., Ertay T., Kargi A., Gure A., et al. Use of technetium-99m HMPAO scintigraphy for the detection of amiodarone lung toxicity in a rabbit model. Eur. J. Nucl. Med. 28:2001;346-350
16. Morelock S.Y., Sahn S.A. Drugs and the pleura. Chest. 116:1999;212-221
17. Barrowcliffe M.P., Jones J.G. Solute permeability of the alveolar capillary barrier. Thorax. 42:1987;1-10
18. Groeneveld A.B. Radionuclide assessment of pulmonary microvascular permeability. Eur. J. Nucl. Med. 24:1997;449-461
19. Coates G., O'Brodovich H. Measurement of pulmonary epithelial permeability with 99mTc-DTPA aerosol. Semin. Nucl. Med. 16:1986;275-284
20. Line B.R. Scintigraphic studies of inflammation in diffuse lung disease. Radiol. Clin. North Am. 29:1991;1095-1114
21. O'Doherty M.J., Peters A.M. Pulmonary technetium-99m diethylene triamine penta-acetic acid aerosol clearance as an index of lung injury. Eur. J. Nucl. Med. 24:1997;81-87
22. Miller R.F., O'Doherty M.J. Pulmonary nuclear medicine. Eur. J. Nucl. Med. 19:1992;355-368
23. Susskind H., Weber D.A., Volkow N.D., Hitzemann R. Increased lung permeability following long-term use of free-base cocaine (crack). Chest. 100:1991;903-909
24. Uh S., Lee S.M., Kim H.T., Chung Y., Kim Y.H., Park C.S. The clearance rate of alveolar epithelium using 99mTc-DTPA in patients with diffuse infiltrative lung diseases. Chest. 106:1994;161-165
25. Kao C.H., Wang R.C., Lin H.T., Yu S.L., Wang S.J., Chiang C.D. Alveolar integrity in pulmonary emphysema using technetium-99m-DTPA and technetium-99m-HMPAO radioaerosol inhalation lung scintigraphy. J. Nucl. Med. 36:1995;68-72
26. Jones J.G., Minty B.D., Lawler P., Hulands G., Crawley J.C.W., Veall N. Increased alveolar epithelial permeability in cigarette smoker. Lancet. 12:1980;66-68
27. Kula M., Gulmez A., Tutus A., Coskun A., Gursoy S., Oymak S. Impaired lung epithelial permeability in hepatitis C virus antibody positive patients detected by 99mTc-DTPA aerosol scintigraphy. Nucl. Med. Commun. 23:2002;441-446
28. Kannan R., Miller S., Singh B.N. Tissue uptake and metabolism of amiodarone after chronic administration in rabbits. Drug Metab. Dispos. 13:1985;646-650
29. Evender E., Wollmer P., Jonson B., Lachmann B. Pulmonary clearance of inhaled 99mTc-DTPA: effect of surfactant depletion by lung lavage. J. Appl. Physiol. 62:1987;1611-1614
30. Groeneveld A.B. Radionuclide assessment of pulmonary microvascular permeability. Eur. J. Nucl. Med. 24:1997;449-461
31. Effros R.M., Mason G.R. Measurement of pulmonary epithelial permeability in vivo. Am. Rev. Respir. Dis. 127:1983;S59-S65. [Suppl.]
32. Martin W.J., Rosenow E.C. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 2). Chest. 93:1988;1242-1248